DK3463325T3 - Mikropartikler omfattende en svovlholdig forbindelse - Google Patents
Mikropartikler omfattende en svovlholdig forbindelse Download PDFInfo
- Publication number
- DK3463325T3 DK3463325T3 DK17735616.9T DK17735616T DK3463325T3 DK 3463325 T3 DK3463325 T3 DK 3463325T3 DK 17735616 T DK17735616 T DK 17735616T DK 3463325 T3 DK3463325 T3 DK 3463325T3
- Authority
- DK
- Denmark
- Prior art keywords
- microparticles
- sulfur
- containing compound
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000011859 microparticle Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pigments, Carbon Blacks, Or Wood Stains (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Accessories For Mixers (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662346969P | 2016-06-07 | 2016-06-07 | |
| GBGB1609940.0A GB201609940D0 (en) | 2016-06-07 | 2016-06-07 | Microparticles |
| PCT/GB2017/051637 WO2017212249A1 (en) | 2016-06-07 | 2017-06-06 | Microparticles comprising a sulphur-containing compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3463325T3 true DK3463325T3 (da) | 2024-01-02 |
Family
ID=56508202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17735616.9T DK3463325T3 (da) | 2016-06-07 | 2017-06-06 | Mikropartikler omfattende en svovlholdig forbindelse |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11369568B2 (da) |
| EP (1) | EP3463325B1 (da) |
| JP (1) | JP7195934B2 (da) |
| KR (1) | KR102412212B1 (da) |
| CN (1) | CN109310654A (da) |
| AU (1) | AU2017277897B2 (da) |
| BR (1) | BR112018075221B1 (da) |
| CA (2) | CA3026743C (da) |
| DK (1) | DK3463325T3 (da) |
| ES (1) | ES2965017T3 (da) |
| FI (1) | FI3463325T3 (da) |
| GB (1) | GB201609940D0 (da) |
| MX (1) | MX2018014278A (da) |
| SG (1) | SG11201810934TA (da) |
| WO (1) | WO2017212249A1 (da) |
| ZA (1) | ZA201807852B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10905660B2 (en) | 2016-06-07 | 2021-02-02 | Novabiotics Limited | Microparticles |
| EP3572068A1 (en) * | 2018-05-22 | 2019-11-27 | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. | New salt of cysteamine for the preparation of highly respirable particles |
| CA3116637A1 (en) * | 2018-10-17 | 2020-04-23 | Novabiotics Limited | Dosage regime |
| BR112023002988A2 (pt) * | 2020-09-03 | 2023-04-04 | Philip Morris Products Sa | Composições em pó ativas de baixa higroscopicidade secas por pulverização |
| US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8901570D0 (sv) * | 1989-05-02 | 1989-05-02 | Draco Ab | Organic salts of cysteine derivatives |
| CN101094651B (zh) | 2004-12-30 | 2011-03-09 | 多贝尔有限公司 | 含有胶原凝集素家族蛋白质或者其变体的喷雾干燥的组合物和其制备方法 |
| AR057623A1 (es) | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
| CA2667072C (en) | 2006-12-22 | 2015-11-24 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Gel useful for the delivery of ophthalmic drugs |
| CN101342155B (zh) * | 2007-07-11 | 2012-01-04 | 天津帝士力投资控股集团有限公司 | 一种(r,r)-福莫特罗吸入粉雾剂及其制备方法 |
| US20120135969A1 (en) * | 2008-11-27 | 2012-05-31 | Boehringer Ingelheim International Gmbh | Novel powdered crystalline medicines for inhalation |
| CN102341105B (zh) * | 2009-02-03 | 2014-09-17 | 微生物公司 | 用作上皮组织、急性和慢性伤口、细菌生物被膜和其他适应症的抗菌剂的铋硫醇 |
| WO2010138419A2 (en) | 2009-05-23 | 2010-12-02 | Obio Pharmaceutical (H.K.) Ltd. | Materials and methods for treating viral infections |
| GB201021186D0 (en) | 2010-12-14 | 2011-01-26 | Novabiotics Ltd | Composition |
| KR101763195B1 (ko) | 2011-05-19 | 2017-07-31 | 사바라 인코포레이티드 | 건조 분말 반코마이신 조성물 및 관련 방법 |
| JP5981123B2 (ja) | 2011-10-11 | 2016-08-31 | サンサ コーポレーション （バルバドス） インク | ニコチン薬の製造法およびその方法により製造される医薬 |
| US9468612B2 (en) * | 2011-10-26 | 2016-10-18 | Seattle Children's Hospital | Cysteamine in the treatment of fibrotic disease |
| NZ630026A (en) * | 2012-02-10 | 2016-06-24 | Whitehead Biomedical Inst | Inhibition of the glycine cleavage system for treatment of cancer |
| ITMI20130572A1 (it) * | 2013-04-10 | 2014-10-11 | Eratech Srl | Composizione comprendente almeno due polveri secche ottenute per spray dry per aumentare la stabilita' della formulazione |
| AU2014331796B2 (en) * | 2013-10-11 | 2020-05-07 | Gilead Sciences, Inc. | Spray dry formulations |
| GB201416716D0 (en) | 2014-09-22 | 2014-11-05 | Novabiotics Ltd | Use |
| ITUA20161799A1 (it) * | 2016-03-18 | 2017-09-18 | Recordati Ind Chimica E Farmaceutica S P A | Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale |
| US10905660B2 (en) * | 2016-06-07 | 2021-02-02 | Novabiotics Limited | Microparticles |
-
2016
- 2016-06-07 GB GBGB1609940.0A patent/GB201609940D0/en not_active Ceased
-
2017
- 2017-06-06 ES ES17735616T patent/ES2965017T3/es active Active
- 2017-06-06 BR BR112018075221-5A patent/BR112018075221B1/pt active IP Right Grant
- 2017-06-06 SG SG11201810934TA patent/SG11201810934TA/en unknown
- 2017-06-06 FI FIEP17735616.9T patent/FI3463325T3/fi active
- 2017-06-06 CA CA3026743A patent/CA3026743C/en active Active
- 2017-06-06 CA CA3096121A patent/CA3096121C/en active Active
- 2017-06-06 US US16/307,990 patent/US11369568B2/en active Active
- 2017-06-06 KR KR1020187035476A patent/KR102412212B1/ko active IP Right Grant
- 2017-06-06 JP JP2018563831A patent/JP7195934B2/ja active Active
- 2017-06-06 WO PCT/GB2017/051637 patent/WO2017212249A1/en unknown
- 2017-06-06 AU AU2017277897A patent/AU2017277897B2/en active Active
- 2017-06-06 CN CN201780035360.7A patent/CN109310654A/zh active Pending
- 2017-06-06 MX MX2018014278A patent/MX2018014278A/es unknown
- 2017-06-06 DK DK17735616.9T patent/DK3463325T3/da active
- 2017-06-06 EP EP17735616.9A patent/EP3463325B1/en active Active
-
2018
- 2018-11-21 ZA ZA2018/07852A patent/ZA201807852B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190016957A (ko) | 2019-02-19 |
| AU2017277897B2 (en) | 2022-09-08 |
| CA3096121C (en) | 2022-11-15 |
| US20190175501A1 (en) | 2019-06-13 |
| SG11201810934TA (en) | 2019-01-30 |
| BR112018075221A2 (pt) | 2019-03-19 |
| JP2019517541A (ja) | 2019-06-24 |
| WO2017212249A1 (en) | 2017-12-14 |
| KR102412212B1 (ko) | 2022-06-23 |
| EP3463325A1 (en) | 2019-04-10 |
| RU2018142841A3 (da) | 2020-09-30 |
| MX2018014278A (es) | 2019-03-14 |
| CA3096121A1 (en) | 2017-12-14 |
| AU2017277897A1 (en) | 2018-12-20 |
| ES2965017T3 (es) | 2024-04-10 |
| EP3463325B1 (en) | 2023-11-08 |
| CA3026743A1 (en) | 2017-12-14 |
| CN109310654A (zh) | 2019-02-05 |
| RU2018142841A (ru) | 2020-06-04 |
| GB201609940D0 (en) | 2016-07-20 |
| CA3026743C (en) | 2024-05-28 |
| ZA201807852B (en) | 2023-05-31 |
| BR112018075221B1 (pt) | 2024-02-06 |
| US11369568B2 (en) | 2022-06-28 |
| JP7195934B2 (ja) | 2022-12-26 |
| FI3463325T3 (fi) | 2023-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3507541T3 (da) | En lysemitterende indretning | |
| DK3612519T3 (da) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser | |
| DK3463325T3 (da) | Mikropartikler omfattende en svovlholdig forbindelse | |
| BR112016030730A2 (pt) | Composto | |
| DK3308018T3 (da) | Drivanordning | |
| SE1651579A1 (sv) | A screw-retaining device | |
| DK3347403T3 (da) | Polyalkoxyfedtforbindelse | |
| FI11939U1 (fi) | Teline | |
| IT201700108243A1 (it) | Confezione | |
| DK3672941T3 (da) | Pyridylpyridonforbindelser | |
| DK3445766T3 (da) | Ny antimikrobiel forbindelse | |
| DK3391870T3 (da) | Pneumomassagehylster | |
| FR3051235B1 (fr) | Palier a roulement | |
| BR212017023420U2 (pt) | um cilíndro | |
| FR3045747B1 (fr) | Palier a roulement | |
| FR3042005B1 (fr) | Palier a roulement | |
| DK3672962T3 (da) | Morpholinylpyridonforbindelser | |
| DK3493949T3 (da) | Kædemonteringsanordning | |
| DE112017002011A5 (de) | Lichtemittierendes bauteil | |
| DK3312181T3 (da) | Imidazodiazepinforbindelse | |
| DK3282082T3 (da) | Spoleindretning | |
| FR3053749B1 (fr) | Palier a roulement | |
| IL263540B1 (en) | Microparticles that include a sulfur-containing compound | |
| FR3056974B1 (fr) | Devidoir a gommettes-2 | |
| CL2018001445S1 (es) | Tapabarro |